BPH progression: concept and key learning from MTOPS, ALTESS, COMBAT, and ALF-ONE.

@article{Roehrborn2008BPHPC,
  title={BPH progression: concept and key learning from MTOPS, ALTESS, COMBAT, and ALF-ONE.},
  author={Claus G. Roehrborn},
  journal={BJU international},
  year={2008},
  volume={101 Suppl 3},
  pages={17-21}
}
Benign prostatic hyperplasia (BPH) represents a significant burden in ageing men due to frequently associated lower urinary tract symptoms (LUTS), which may impair quality of life. BPH is also a progressive disease, mainly characterized by a deterioration of LUTS over time, and in some patients by the occurrence of serious outcomes such as acute urinary retention (AUR) and need for BPH-related surgery. The goals of therapy for BPH are not only to improve bothersome LUTS but also to identify… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 53 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 16 references

Safety and tolerability of dutasteride , tamsulosin and a combination of dutasteride and tamsulosin : two - year results from the Combination of Avodart ® and Tamsulosin ( CombAT ) study

R Roehrborn, P Siami, J Barkin, R Damiao, F Montorsi
Urology • 2007

The natural history of benign prostatic hyperplasia

JM Fitzpatrick
BJU Int 2006; • 2006

Similar Papers

Loading similar papers…